News

A team of doctors and scientists have successfully treated a rare genetic condition with the first-ever personalized ...
A team of doctors at the Children's Hospital of Philadelphia and Penn Medicine treated a baby with a gene editing technology ...
05. NEW ORLEANS — Last year, hundreds of people poured in to hear Peter Marks, the Food and Drug Administration’s head of biologics, speak at the American Society of Gene and Cell Therapy ...
A gene therapy recently approved by the FDA to treat patients with Sickle Cell Anemia is now being administered in St. Louis.
You can reach Jason on Signal at JasonMast.05. NEW ORLEANS — Greetings from the home stretch of American Society of Gene and Cell Therapy conference, where everyone is still talking about Baby ...
Mass photometry enables rapid, purification-free quantification of rAAV vectors, offering a faster solution for gene therapy ...
An infant in Philadelphia has been successfully treated with a customized Crispr gene-editing therapy for a rare and deadly disease, doctors reported Thursday—a breakthrough in the futuristic ...
A new gene therapy developed at the Children's Hospital of Philadelphia has been approved by the FDA and is being used to transform lives. The first patient to receive this gene therapy after it ...
The β 2 common integrin subunit CD18 is essential for leukocyte–endothelial adhesion and extravasation to inflamed or infected tissue. Damaging variants in ITGB2, which encodes CD18, cause ...
The FDA approved prademagene zamikeracel (Zevaskyn) for treating adults and children with the blistering wounds caused by recessive dystrophic epidermolysis bullosa (RDEB), Abeona Therapeutics ...